Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Korean RA Subjects on Methotrexate
NCT00235859Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2003
- Modality
- Monoclonal Antibodies
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Adalimumab + MTX with Placebo + MTX (2 arms). Primary endpoint: American College of Rheumatology 20% Improvement at 24 weeks. Started Jul 2003; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00235859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235859.